BioReliance
 
Home About Us Services What's Your Product? Resources Careers Contact Us
  Home
 

News

New protein array platform that offers greater sensitivity, reduced testing time and reliable results. The platform, brand-named ReliArray™, can simultaneously screen for four non-human pathogens in animal serum.
Click here to read the press release.

BioReliance Announces First Commercial Use of HyMy™ Assay: Provides Enhanced Mycoplasma Detection with Greater Speed
Click here to read the press release.

 

   

Announcing
Innovations in Toxicology at BioReliance:
23rd Annual Genotoxicity and Carcinogenicity Workshop

April 23-24, 2009

Click here for more information and registration

 

BioReliance provides comprehensive toxicology services that can speedily move your product from discovery to market. We have been a scientific leader in toxicology for more than 50 years – from safety testing the first polio vaccines in the 1950’s to validating new transgenic mouse models for carcinogenicity testing.

Toxicology Introduction

Our services include a broad spectrum of in vitro and in vivo toxicology testing services designed in accordance with international guidelines and are conducted in full compliance with GLP regulations. Our expertise uniquely qualifies us to custom design testing strategies even when they involve new or novel products. These services are provided to producers of traditional pharmaceuticals, biopharmaceuticals, medical devices, gene therapies, industrial chemicals and consumer products. Our 50,000-ft2 state-of-the-art facility and dedicated staff continue to lead and advance the field of toxicology with the implementation of the latest technologies that helps clients register products internationally.

Our areas of expertise include:

Genetic Toxicology
We offer complete genetic toxicology services for the detection of toxic, mutagenic, clastogenic, and morphological transforming activity in a number of well-characterized test systems.

Mammalian Toxicology
BioReliance has extensive experience in the development and application of toxicological methodologies using animal models.

 

What's new?
Comet assay (in vivo and now in vitro )
SHE assay
Updated information - Transgenic Carcinogenicity Studies
Updated information - Bacterial Reverse Mutation (Ames) assay

 

 

 

 

 
for further information and enquiries please contact: info@bioreliance.com